Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose
P Rigo, P Paulus, BJ Kaschten, R Hustinx… - European journal of …, 1996 - Springer
Positron emission tomography (PET) is now primarily used in oncological indication owing
to the successful application of fluorine-18 fluorodeoxyglucose (FDG) in an increasing …
to the successful application of fluorine-18 fluorodeoxyglucose (FDG) in an increasing …
[BOOK][B] Medical image registration
Image registration is the process of systematically placing separate images in a common
frame of reference so that the information they contain can be optimally integrated or …
frame of reference so that the information they contain can be optimally integrated or …
Whole body PET for the evaluation of bony metastases in patients with breast cancer: comparison with 99Tcm-MDP bone scintigraphy
M Ohta, Y Tokuda, Y Suzuki, M Kubota… - Nuclear medicine …, 2001 - journals.lww.com
The purpose of this study was to determine the potential role of positron emission
tomography (PET) using 2-[18 F]-fluoro-2-deoxy-D-glucose (FDG) for the evaluation of bony …
tomography (PET) using 2-[18 F]-fluoro-2-deoxy-D-glucose (FDG) for the evaluation of bony …
Visualization and quantification of breast cancer biomechanical properties with magnetic resonance elastography
A quasistatic magnetic resonance elastography (MRE) method for the evaluation of breast
cancer is proposed. Using a phase contrast, stimulated echo MRI approach, strain imaging …
cancer is proposed. Using a phase contrast, stimulated echo MRI approach, strain imaging …
Advantages and limitations of FDG PET in the follow-up of breast cancer
P Lind, I Igerc, T Beyer, P Reinprecht… - European journal of …, 2004 - Springer
Abstract 18F-Fluoro-2-deoxy-d-glucose positron emission tomography (FDG PET) has been
evaluated in breast cancer for the characterisation of primary tumours, lymph node staging …
evaluated in breast cancer for the characterisation of primary tumours, lymph node staging …
Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: preliminary experience
PB Hathaway, DA Mankoff, KR Maravilla… - Radiology, 1999 - pubs.rsna.org
PURPOSE: To assess the performance and potential clinical effects of combined 2-[fluorine
18] fluoro-2-deoxy-d-glucose (FDG) positron emission tomography (PET) and magnetic …
18] fluoro-2-deoxy-d-glucose (FDG) positron emission tomography (PET) and magnetic …
[PDF][PDF] Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer
F Crippa, R Agresti, E Seregni, M Greco… - Journal of Nuclear …, 1998 - Soc Nuclear Med
Methods: The presurgical, noninvasivestagingof axillarynodes for mé tastaseswas
prospectively investigated in 68 patients who were diagnosed with primary breast cancer …
prospectively investigated in 68 patients who were diagnosed with primary breast cancer …
FDG PET and other imaging modalities in the primary diagnosis of suspicious breast lesions
K Scheidhauer, C Walter, MD Seemann - European journal of nuclear …, 2004 - Springer
Mammography is the primary imaging modality for screening of breast cancer and
evaluation of breast lesions (T staging). Ultrasonography is an adjunctive tool for …
evaluation of breast lesions (T staging). Ultrasonography is an adjunctive tool for …
Qualitative [18F]FDG positron emission tomography in primary breast cancer: clinical relevance and practicability
K Scheidhauer, A Scharl, U Pietrzyk, R Wagner… - European journal of …, 1996 - Springer
Positron emission tomography (PET) using fluorine-18 2-deoxy-2-fluoro-d-glucose (FDG) is
of potential value for the diagnosis of malignant tumours. The aim of this study was to …
of potential value for the diagnosis of malignant tumours. The aim of this study was to …
Staging of the Axilla in Breast Cancer: Accurate: In Vivo: Assessment Using Positron Emission Tomography With 2-(Fluorine-18)-Fluoro-2-Deoxy-D-Glucose
IC Smith, KN Ogston, P Whitford, FW Smith… - Annals of …, 1998 - journals.lww.com
Objective To evaluate the ability of positron emission tomography (PET) with 18 F-fluoro-2-
deoxy-D-glucose (18 F-FDG) to determine noninvasively axillary lymph node status in …
deoxy-D-glucose (18 F-FDG) to determine noninvasively axillary lymph node status in …